Mesirow Financial Investment Management, Inc. Amicus Therapeutics, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.3 Billion
- Q2 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 19,003 shares of FOLD stock, worth $214,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,003Holding current value
$214,733% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
278Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$323 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$317 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$310 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$275 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$239 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.17B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...